SYNHELIX

synhelix-logo

SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply.

#Website #More

SYNHELIX

Social Links:

Industry:
Biotechnology

Founded:
2019-01-01

Address:
ร‰vry, Ile-de-France, France

Country:
France

Website Url:
http://www.synhelix.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
Google Maps OVH


Official Site Inspections

http://www.synhelix.com Semrush global rank: 11.46 M Semrush visits lastest month: 162

  • Host name: a2b7bf3398455f345.awsglobalaccelerator.com
  • IP address: 99.83.161.153
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "SynHelix"

HOME - Synhelix

Careers at SynHelix We are seeking for amazing scientists and executives to build with us the most exciting synthetic biology core platform. If you are as โ€ฆSee details»

SynHelix - Crunchbase Company Profile & Funding

Organization. SynHelix . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. ... SynHelix seeks to break the bottleneck of biotherapeutics development which โ€ฆSee details»

SynHelix Company Profile 2024: Valuation, Investors ... - PitchBook

SynHelix General Information Description. Operator of a biotechnology company intended to develop an affordable DNA synthesis technology. The company is engaged in generating any โ€ฆSee details»

Univercells acquires SynHelix - 2022-01-06 - Crunchbase

SynHelix SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply. Acquiring Organization: Univercells Univercells is a One โ€ฆSee details»

Univercells acquires SynHelix, entering into synthetic biology and โ€ฆ

Jan 6, 2022 Univercells S.A. Univercells S.A. SynHelix Alexandra Deschner Cécile Hisette Irina Gbalou IR & International Media Relations Belgian Media Relations CEO โ€ฆSee details»

Univercells acquires Synhelix, entering into synthetic ... - Quantoom

Jan 13, 2022 Irina Gbalou, CEO and co-founder of SynHelix added: โ€œWe are really thrilled to join the Univercells Group. SynHelix was founded with the mission of making an impact in โ€ฆSee details»

SynHelix - Products, Competitors, Financials, Employees, โ€ฆ

SynHelix offers a proprietary, enzyme-based DNA synthesis solution that promises a gigaprep-scale DNA production for life sciences laboratories and industries that need large amounts of โ€ฆSee details»

Univercells acquires SynHelix, entering into synthetic biology and โ€ฆ

Jan 6, 2022 The SynHelix team is looking forward to working alongside Quantoomโ€™s strong scientific, development and management teams to advance the next-generation vaccines โ€ฆSee details»

About Us - Synhelix

SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply, given the exponentially increasing demands from the pharma and โ€ฆSee details»

SynHelix - Company Profile - Tracxn

Oct 20, 2024 SynHelix ranks 32nd among 47 active competitors. 16 of its competitors are funded while 9 have exited. Overall, SynHelix and its competitors have raised over $1.14B in โ€ฆSee details»

Univercells acquires SynHelix, entering into synthetic biology and โ€ฆ

Feb 14, 2022 SynHelix was founded with the mission of making an impact in synthetic biology, which faces a bottleneck in DNA supply. Alain Huriez and the entire AdBio partners team โ€ฆSee details»

Univercells acquires SynHelix to advance DNA synthesis

Jan 7, 2022 The founders of SynHelix and AdBio will subsequently become minority shareholders of Univercells, according to the companies. Headquartered in Évry โ€ฆSee details»

Univercells acquires SynHelix, enters synthetic biology field

Jan 6, 2022 โ€œThe SynHelix team is looking forward to working alongside Quantoomโ€™s strong scientific, development and management teams to advance the next-generation vaccines โ€ฆSee details»

Acquisition brings combined approach to Synthetic DNA pursuit

SynHelix was founded with the mission of making an impact in synthetic biology, which faces a bottleneck in DNA supply. Alain Huriez and the entire AdBio partners team believed in us from โ€ฆSee details»

Investors - Synhelix

SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply, given the exponentially increasing demands from the pharma and โ€ฆSee details»

SynHelix | EU-Startups

SynHelix seeks to break the bottleneck of biotherapeutics development which faces unsolved DNA constructs supply, given the exponentially increasing demands from the pharma and โ€ฆSee details»

Partners - Synhelix

Since May 2019, SynHelix is accompanied by the healthcare accelerator program of WILCO after being selected by a jury of experts (composed by entrepreneurs, business angels and โ€ฆSee details»

Irina Gbalou - Synhelix

Before founding SynHelix, Irina managed a project that aimed at engineering a human DNA polymerase to switch its activity and synthesize RNA fragments, useful to generate aptamers โ€ฆSee details»

Ahmed Said - Synhelix

Synhelix โ†’ Ahmed Said. Ahmed Said. Chief Technological Officer and co-founder. LinkedIn; Ahmed is a passionate biotechnology engineer. He is particularly resourceful in optimizing โ€ฆSee details»

Technology - Synhelix

SynHelix team is devoted to the development of the most robust and scalable DNA synthesis technology using a specifically engineered high-perfomance enzyme with the advantages of: - โ€ฆSee details»